drugset / Trial / NCT01524497
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of trazodone hydrochloride prolonged-release tablets for treatment of depression in Chinese population.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-08
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trazodone | Small molecule | 75 mg | — |
| Comparator | Trazodone | Small molecule | 150 mg | — |